KUKJEON PHARMACEUTICAL Balance Sheet Health
Financial Health criteria checks 3/6
KUKJEON PHARMACEUTICAL has a total shareholder equity of ₩99.5B and total debt of ₩76.3B, which brings its debt-to-equity ratio to 76.7%. Its total assets and total liabilities are ₩234.5B and ₩135.0B respectively. KUKJEON PHARMACEUTICAL's EBIT is ₩2.0B making its interest coverage ratio 0.3. It has cash and short-term investments of ₩71.3B.
Key information
76.7%
Debt to equity ratio
₩76.33b
Debt
| Interest coverage ratio | 0.3x |
| Cash | ₩71.33b |
| Equity | ₩99.55b |
| Total liabilities | ₩134.95b |
| Total assets | ₩234.50b |
Financial Position Analysis
Short Term Liabilities: A307750's short term assets (₩127.5B) exceed its short term liabilities (₩109.1B).
Long Term Liabilities: A307750's short term assets (₩127.5B) exceed its long term liabilities (₩25.9B).
Debt to Equity History and Analysis
Debt Level: A307750's net debt to equity ratio (5%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if A307750's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: A307750's debt is not well covered by operating cash flow (16.5%).
Interest Coverage: A307750's interest payments on its debt are not well covered by EBIT (0.3x coverage).